Search clinical trials for: transitional cell
Total 49625 results
-
Aprea TherapeuticsCompletedGastric Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Advanced Solid Tumor | Urothelial CarcinomaUnited States
-
Incyte CorporationTerminatedMetastatic Urothelial Carcinoma | Unresectable Urothelial CarcinomaSpain, France, United States, Italy, Japan, Ireland, Slovakia, Austria, Belgium, Canada, Finland, Germany, Poland, Portugal, Romania, United Kingdom
-
University of Turin, ItalyTesaro, Inc.Completed
-
University Health Network, TorontoCanadian Urological Association; Canadian Urologic Oncology Group; Bladder Cancer...TerminatedBladder Cancer | Bladder Urothelial CarcinomaCanada
-
Silverback TherapeuticsWithdrawnSquamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Urothelial Carcinoma | Hormone Receptor-positive/HER2-negative Breast Cancer
-
National Cancer Institute (NCI)TerminatedUrothelial CancerUnited States
-
Indiana UniversityTerminatedProstate Cancer | Urothelial CarcinomaUnited States
-
Samsung Medical CenterActive, not recruitingUrothelial CarcinomaKorea, Republic of
-
Emory UniversityTerminatedBladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Squamous Cell Carcinoma of the BladderUnited States
-
Eisai Inc.PharmaBio Development Inc.TerminatedBladder CancerUnited Kingdom, Netherlands, Spain, Germany, United States, Ukraine
-
Yale UniversityWithdrawnTransitional Cell CarcinomaUnited States
-
Seth LernerAstraZeneca; Cytogen CorporationCompletedUrinary Bladder NeoplasmsUnited States, Italy
-
Lee's Pharmaceutical LimitedActive, not recruitingAdvanced Urothelial CarcinomaChina
-
Lipac Oncology LLCTesoRx Pharma, LLCCompletedUrologic Neoplasms | Urogenital Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Non-Muscle Invasive Bladder Cancer | Urinary Bladder | Bladder Cancer Cell TransitionalUnited States
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedUrothelial CarcinomaFrance
-
Mesoblast, Inc.Juvenile Diabetes Research FoundationCompletedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent | Juvenile DiabetesUnited States
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, France, Belgium, Israel, Spain, United Kingdom, Korea, Republic of, Taiwan, Australia, Netherlands, Japan, Germany, Ukraine, Canada, Ireland, Italy, Poland, Russian Federation
-
University of Michigan Rogel Cancer CenterTerminatedUrothelial CarcinomaUnited States
-
PfizerCompletedNSCLC | SCCHN | Part 1 | MELANOMA | OVCA | SARCOMA | OTHER SOLID TUMORS | Part 1 and 2 | UROTHELIAL CARCINOMAUnited States, Korea, Republic of, Russian Federation, Poland, Malaysia, Bulgaria, Ukraine
-
Memorial Sloan Kettering Cancer CenterAstraZenecaCompletedAdenocarcinoma of the Bladder | Squamous Cell Carcinoma of the Bladder | Metastatic Bladder Cancer | Non-Transitional Cell Carcinoma of the Urothelial Tract | Small Cell of the BladderUnited States
-
Beijing Huanxing Cancer HospitalNewish Technology (Beijing) Co., Ltd.TerminatedUrinary Bladder NeoplasmChina
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, Spain, Hungary, Israel, United Kingdom, Korea, Republic of, Taiwan, Denmark, France, Netherlands, Italy, Canada, Japan, Turkey, Germany, Ireland, Australia, Russian Federation
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedStage III Renal Cell Cancer | Recurrent Bladder Carcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Infiltrating Bladder Urothelial Carcinoma | Stage II Bladder Urothelial Carcinoma | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage I Renal Cell Cancer | Stage II Renal Cell CancerUnited States
-
Fox Chase Cancer CenterStand Up To Cancer; Van Andel Research InstituteActive, not recruitingUrothelial CarcinomaUnited States
-
AIO-Studien-gGmbHBristol-Myers SquibbActive, not recruitingTransitional Cell Carcinoma | Metastatic Cancer | Advanced CancerGermany, Austria
-
GOG FoundationNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube... and other conditionsUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedOvarian Endometrioid Adenocarcinoma | Ovarian Undifferentiated Carcinoma | Fallopian Tube Carcinoma | Ovarian Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell... and other conditionsUnited States
-
GOG FoundationNational Cancer Institute (NCI)Active, not recruitingOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma and other conditionsUnited States
-
Erasmus Medical CenterMerck Sharp & Dohme LLCActive, not recruitingBiomarkers | Transitional Cell Carcinoma of the BladderNetherlands
-
Cadila PharnmaceuticalsCompleted
-
Daiichi Sankyo, Inc.Bristol-Myers Squibb; AstraZenecaActive, not recruitingBreast Cancer | Urothelial CarcinomaUnited States, Spain, Italy, Belgium, France, Germany, United Kingdom
-
Chinese PLA General HospitalCompleted
-
Memorial Sloan Kettering Cancer CenterNovartisCompletedMetastatic Transitional Cell Carcinoma of the UrotheliumUnited States
-
Latin American Cooperative Oncology GroupTerminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedMetastatic Urothelial CarcinomaUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedTransitional Cell Carcinoma of BladderItaly
-
National Cancer Institute (NCI)NRG OncologyCompletedOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma and other conditionsUnited States
-
Nucleix Ltd.CompletedBladder CancerNetherlands, Israel, Germany, Spain
-
Hellenic Cooperative Oncology GroupCompletedBladder Cancer
-
CG Oncology, Inc.TerminatedCarcinoma in Situ | Transitional Cell Carcinoma | Bladder Cancer | Carcinoma in Situ Concurrent With Papillary TumorsUnited States
-
ImmunityBio, Inc.Withdrawn
-
UNICANCERCompletedKRAS Gene Mutation | Infiltrating Urothelial CarcinomaFrance
-
BioNTech US Inc.Bristol-Myers SquibbCompletedMelanoma | Carcinoma, Non-Small-Cell Lung | Lung Cancer | Urinary Bladder Cancer | Skin Cancer | Transitional Cell Carcinoma of the Bladder | Malignant Melanoma | Bladder TumorsUnited States
-
UNICANCERCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerFrance
-
Cairo UniversityUnknownUrothelial Carcinoma Bladder | High-Risk CancerEgypt
-
Clinique Beau SoleilCepheid; Team Languedoc Mutualité / Nouvelles technologiesCompletedNon-Invasive Bladder Urothelial Carcinoma | Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade | Non-Invasive Bladder Papillary Urothelial Carcinoma, High GradeFrance
-
Fundacio PuigvertNucleix Ltd.UnknownUrologic Neoplasms | Urologic CancerSpain
-
Principia Biopharma, a Sanofi CompanyTerminatedSolid Tumors | Metastatic Urothelial Carcinoma & Renal Pelvis & UreterSpain, United States
-
UroGen Pharma Ltd.CompletedCarcinoma, Transitional Cell | Transitional Cell Carcinoma of Renal PelvisUnited States, Israel
-
AdaptimmuneCompletedMelanoma | Head and Neck Cancer | Urothelial Carcinoma | Bladder Urothelial CarcinomaUnited States, Canada, Spain